By a procedure similar to that for methoxyallene (Procedure 1), TMSE-allene (411 mg, 2.63 mmol) in THF (40 mL) was treated with n-BuLi (2.5 M in hexanes;
Preparation of 1,2-oxazines (3S)-3c and (3R)-3c
By the procedure similar to that for methoxyallene (Procedure 1), benzyloxyallene (719 mg, 4.92 mmol) in THF (45 mL) was treated with n-BuLi (2.5 M in hexanes;
1.8 mL, 4.5 mmol) at -40 °C, followed by slow addition of nitrone 1a (540 mg, 2.05 mmol) in dry THF (10 mL) at -130 °C. The mixture was allowed to reach -80 °C S4 within 1.5 h. After standard workup, crude products were separated on a column (silica gel, hexane/ethyl acetate 6:1) to give enriched fractions of (3S)-3c (235 mg) and (3R)-3c (394 mg) as pale yellow oils. Each fraction was additionally chromatographed (silica gel, hexane/acetone 6:1, and 5:1, resp.) to give pure (3S)-3c
(182 mg, 21%) and (3R)-3c (371 mg, 44%) as colourless oils. 
Isolation of by-products 4 and 5
Compounds 4 (8 mg, 1%) and 5 (38 mg, 3%) were isolated as colourless oils from the reaction of lithiated methoxyallene (2.4 equiv.) generated from methoxyallene (640 mg, 0.77 mL, 9.13 mmol) and n-BuLi (2.5 M in hexanes; 3. 
Hydroxylation of (3R)-3a
By the procedure similar to that for (3S)-3a (Procedure 2), compound (3R)-3a
(810 mg, 2.43 mmol) in THF (60 mL) was treated with a solution of BF 3 THF (1 M in THF, 9.8 mL, 9.8 mmol). After standard oxidative workup, the crude mixture was chromatographed (silica gel, hexane/ethyl acetate 1:1) to yield an enriched fraction of 10 (186 mg, first eluted) and pure 11 (568 mg, 66%). Additional chromatography purification of 10 (silica gel, dichloromethane/acetone 9:1) yielded an analytically pure sample (109 mg, 13%). Both alcohols were isolated as colourless oils. 
Synthesis of 14 by demethylation of 12
To a solution of 1,2-oxazine 12 (59 mg, 0.28 mmol) in CH 2 Cl 2 (4.4 mL) a solution of 
(3S,4R,5R,3a'S,4'S,6a'S)-5-Benzyloxy-2-(2',2'-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4'-yl)-4-methoxy-3-phenyl-[1,2]oxazine (18):
A solution of 7 (261 mg, 0.74 mmol) in DMF (3 mL) was added to NaH (60% in mineral oil; 46 mg, 1.04 mmol) at 0 °C. Benzyl bromide (160 mg, 0.89 mmol) was added and the solution was stirred at room temperature overnight. Then H 2 O (6 mL) was added, the aqueous layer was extracted with Et 2 O (3 × 25 mL), and the combined organics dried with MgSO 4 . After filtration, the solvent was removed in S16 vacuo. The crude product was purified by column chromatography (silica gel, hexane/ethyl acetate, 5:1) to give compound 18 as a colourless oil (278 mg, 85% 
(3S,4R,5R)-4-Methoxy-3-phenyl-5-trimethylsilanyloxy-[1,2]oxazinane (21):
O NH Ph MeO TMSO To a solution of 1,2-oxazine 13 (70 mg, 0.33 mmol) in dry CH 2 Cl 2 (1.5 mL) were added dropwise at 0 °C imidazole (36 mg, 0.52 mmol), DMAP (2 mg, 5 mol%) and TMSCl (63 µL, 54 mg, 0.50 mmol) in CH 2 Cl 2 (3 mL). The reaction mixture was allowed to reach room temperature and stirred overnight. Then CH 2 Cl 2 (2 mL) was added followed by H 2 O (2 mL), and the layers were separated. The aqueous layer was extracted with three portions of CH 2 Cl 2 (5 mL each), the combined organics were washed with brine, dried over Na 2 SO 4 , and then filtered, and the solvents were removed under reduced pressure. Purification by column chromatography (silica gel, hexane/ethyl acetate 2:1) yielded 21 (85 mg, 90%) as a colourless oil. [α] D 22 = +88. 
